This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Wei Mu: Innovator in Lung Cancer Treatment Decision Support
Introduction
Wei Mu is a prominent inventor based in Tampa, Florida, known for his significant contributions to the field of cancer treatment. His innovative approach focuses on improving decision-making processes for lung cancer therapies, particularly for non-small cell lung cancer (NSCLC). With a keen understanding of the complexities involved in cancer treatment, Mu has developed methods that enhance the predictive capabilities of treatment responses.
Latest Patents
Wei Mu holds a patent for a groundbreaking method titled "Radiomics-based treatment decision support for lung cancer." This patent addresses the challenges faced in selecting appropriate treatment strategies, such as tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs). The method utilizes advanced imaging techniques, including positron emission tomography (PET) and computed tomography (CT), to analyze tumor characteristics. By generating a radiomic signature and score, the method predicts patient responsiveness to various therapies, thereby facilitating more personalized treatment plans. He has 1 patent to his name.
Career Highlights
Mu is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he collaborates with leading experts in cancer research. His work is instrumental in bridging the gap between imaging technology and clinical decision-making, ultimately aiming to improve patient outcomes in lung cancer treatment.
Collaborations
One of his notable collaborators is Matthew B Schabath, with whom he has worked on various research initiatives aimed at enhancing cancer treatment methodologies. Their combined expertise contributes to the advancement of innovative solutions in oncology.
Conclusion
Wei Mu's contributions to lung cancer treatment decision support exemplify the impact of innovation in healthcare. His patented methods not only enhance the understanding of tumor behavior but also pave the way for more effective treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile